SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-040812
Filing Date
2022-02-14
Accepted
2022-02-14 12:54:52
Documents
2
Group Members
ESSEX WOODLANDS HEALTH VENTURES V, L.L.C.IMMANUEL THANGARAJJ. DOUGLAS EPLETTJEFF HIMAWANMARTIN P. SUTTER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d317891dsc13da.htm SC 13D/A 110895
2 EXHIBIT 1 d317891dex991.htm EX-99.1 10052
  Complete submission text file 0001193125-22-040812.txt   122761
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Subject) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-78982 | Film No.: 22628394
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 WATERWAY AVENUE SUITE 225 WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 WOODLANDS TX 77380 2813648338
ESSEX WOODLANDS HEALTH VENTURES FUND V LP (Filed by) CIK: 0001120812 (see all company filings)

IRS No.: 760647046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A